Brighten Optix Corporation
TWO: 6747.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Richard Wu
- Headquarters
- Taipei, Taiwan
- IPO year
- 2019
- Market cap
- NT$5.4B
- Website
- https://www.brightenoptix.com.tw
Loading 6747…
Loading profile data…Frequently asked questions about 6747
What does Brighten Optix Corporation (6747.TWO) do?
Brighten Optix Corporation researches and develops, manufactures, and sells specialty contact lenses in Taiwan and the Asia Pacific region. The company offers hard contact lenses under HiClear and Soclear brands; soft contact lenses under Brio+moist, iDealsoft, and MyOKvision names; contact lens care potion under the Oxy vision plus Briomoist an...
Where does 6747.TWO trade?
Brighten Optix Corporation (6747.TWO) trades on the Taipei Exchange.
What sector is 6747.TWO in?
Brighten Optix Corporation (6747.TWO) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Brighten Optix Corporation?
Richard Wu is the chief executive officer of Brighten Optix Corporation (6747.TWO).
Where is Brighten Optix Corporation headquartered?
Brighten Optix Corporation is headquartered in Taiwan.
Does 6747.TWO pay a dividend?
Yes — Brighten Optix Corporation (6747.TWO) paid a trailing twelve-month dividend of TWD 9.19 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 6747.TWO go public?
Brighten Optix Corporation (6747.TWO) completed its initial public offering in 2019.